Fc-Receptor Targeted Therapies for the Treatment of <i>Myasthenia gravis</i>

Fc-Receptor Targeted Therapies for the Treatment of <i>Myasthenia gravis</i>

<i>Myasthenia gravis</i> (MG) is an autoimmune disease in which immunoglobulin G (IgG) antibodies (Abs) bind to acetylcholine receptors (AChR) or to functionally related molecules in the postsynaptic membrane at the neuromuscular junction. IgG crystallizable fragment (Fc)-mediated effect...

Full description

Bibliographic Details
Main Authors: Christian W. Keller, Marc Pawlitzki, Heinz Wiendl, Jan D. Lünemann
Format: Article
Language:English
Published: MDPI AG 2021-05-01
Series:International Journal of Molecular Sciences
Subjects:
<i>myasthenia gravis</i>
antibody
IgG
Fc
Fc receptor
immunotherapy
Online Access:https://www.mdpi.com/1422-0067/22/11/5755

Internet

https://www.mdpi.com/1422-0067/22/11/5755

Similar Items